Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal

By: via Benzinga
Following the announcement of the Johnson & Johnson's (NYSE: JNJ) $1.75 billion cash deal for privately held Alios BioPharma, ...
Related Stocks:
Achison Inc Johnson & Johnson Macy's
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.